Effects of inhaled corticosteroids on growth in asthmatic children: A comparison of fluticasone propionate with budesonide

Ceyda Acun, Nazan Tomac, Bahri Ermis, Gulzade Onk

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

In asthmatic children inhaled corticosteroids are widely used. However, there are some concerns about the systemic adverse effects of these drugs, especially in the growing child. We performed this prospective study in order to compare the effects of 400 μg/day of budesonide (BUD) and 250 μg/day of fluticasone propionate (FP) on growth in prepubertal (aged 4-11.5 years), moderate persisting asthmatic children. One hundred patients (51 boys and 49 girls), who were randomized into two groups, were recruited for the study. The first group was treated with BUD, 2x 200 μg/day, and the second group was treated with FP, 2x 125 μg/day, by using a medium-size volume-spacer metered-dose inhaler. Growth in children with asthma who were treated by inhaled corticosteroids was calculated by growth velocity over a 12-month period. Comparisons between treatment groups were calculated by t-test and chi-square test. There were no significant differences between BUD and FP groups for sex, age, first height, and growth velocity. Moderate persisting, prepubertal asthmatic children treated with 250 μg/day of FP appeared to have no different linear growth than those children who received 400 μg/day of BUD.

Original languageEnglish (US)
Pages (from-to)204-206
Number of pages3
JournalAllergy and Asthma Proceedings
Volume26
Issue number3
StatePublished - May 1 2005

Fingerprint

Budesonide
Adrenal Cortex Hormones
Growth
Metered Dose Inhalers
Chi-Square Distribution
Fluticasone
Asthma
Age Groups
Prospective Studies
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Effects of inhaled corticosteroids on growth in asthmatic children : A comparison of fluticasone propionate with budesonide. / Acun, Ceyda; Tomac, Nazan; Ermis, Bahri; Onk, Gulzade.

In: Allergy and Asthma Proceedings, Vol. 26, No. 3, 01.05.2005, p. 204-206.

Research output: Contribution to journalArticle

@article{a4bad1f04ac84b128221567871bee554,
title = "Effects of inhaled corticosteroids on growth in asthmatic children: A comparison of fluticasone propionate with budesonide",
abstract = "In asthmatic children inhaled corticosteroids are widely used. However, there are some concerns about the systemic adverse effects of these drugs, especially in the growing child. We performed this prospective study in order to compare the effects of 400 μg/day of budesonide (BUD) and 250 μg/day of fluticasone propionate (FP) on growth in prepubertal (aged 4-11.5 years), moderate persisting asthmatic children. One hundred patients (51 boys and 49 girls), who were randomized into two groups, were recruited for the study. The first group was treated with BUD, 2x 200 μg/day, and the second group was treated with FP, 2x 125 μg/day, by using a medium-size volume-spacer metered-dose inhaler. Growth in children with asthma who were treated by inhaled corticosteroids was calculated by growth velocity over a 12-month period. Comparisons between treatment groups were calculated by t-test and chi-square test. There were no significant differences between BUD and FP groups for sex, age, first height, and growth velocity. Moderate persisting, prepubertal asthmatic children treated with 250 μg/day of FP appeared to have no different linear growth than those children who received 400 μg/day of BUD.",
author = "Ceyda Acun and Nazan Tomac and Bahri Ermis and Gulzade Onk",
year = "2005",
month = "5",
day = "1",
language = "English (US)",
volume = "26",
pages = "204--206",
journal = "Allergy and Asthma Proceedings",
issn = "1088-5412",
publisher = "OceanSide Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Effects of inhaled corticosteroids on growth in asthmatic children

T2 - A comparison of fluticasone propionate with budesonide

AU - Acun, Ceyda

AU - Tomac, Nazan

AU - Ermis, Bahri

AU - Onk, Gulzade

PY - 2005/5/1

Y1 - 2005/5/1

N2 - In asthmatic children inhaled corticosteroids are widely used. However, there are some concerns about the systemic adverse effects of these drugs, especially in the growing child. We performed this prospective study in order to compare the effects of 400 μg/day of budesonide (BUD) and 250 μg/day of fluticasone propionate (FP) on growth in prepubertal (aged 4-11.5 years), moderate persisting asthmatic children. One hundred patients (51 boys and 49 girls), who were randomized into two groups, were recruited for the study. The first group was treated with BUD, 2x 200 μg/day, and the second group was treated with FP, 2x 125 μg/day, by using a medium-size volume-spacer metered-dose inhaler. Growth in children with asthma who were treated by inhaled corticosteroids was calculated by growth velocity over a 12-month period. Comparisons between treatment groups were calculated by t-test and chi-square test. There were no significant differences between BUD and FP groups for sex, age, first height, and growth velocity. Moderate persisting, prepubertal asthmatic children treated with 250 μg/day of FP appeared to have no different linear growth than those children who received 400 μg/day of BUD.

AB - In asthmatic children inhaled corticosteroids are widely used. However, there are some concerns about the systemic adverse effects of these drugs, especially in the growing child. We performed this prospective study in order to compare the effects of 400 μg/day of budesonide (BUD) and 250 μg/day of fluticasone propionate (FP) on growth in prepubertal (aged 4-11.5 years), moderate persisting asthmatic children. One hundred patients (51 boys and 49 girls), who were randomized into two groups, were recruited for the study. The first group was treated with BUD, 2x 200 μg/day, and the second group was treated with FP, 2x 125 μg/day, by using a medium-size volume-spacer metered-dose inhaler. Growth in children with asthma who were treated by inhaled corticosteroids was calculated by growth velocity over a 12-month period. Comparisons between treatment groups were calculated by t-test and chi-square test. There were no significant differences between BUD and FP groups for sex, age, first height, and growth velocity. Moderate persisting, prepubertal asthmatic children treated with 250 μg/day of FP appeared to have no different linear growth than those children who received 400 μg/day of BUD.

UR - http://www.scopus.com/inward/record.url?scp=24944492472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944492472&partnerID=8YFLogxK

M3 - Article

C2 - 16119035

AN - SCOPUS:24944492472

VL - 26

SP - 204

EP - 206

JO - Allergy and Asthma Proceedings

JF - Allergy and Asthma Proceedings

SN - 1088-5412

IS - 3

ER -